Skip to main content
. 2012 Oct 2;12:444. doi: 10.1186/1471-2407-12-444

Figure 2.

Figure 2

Transitional serum biomarkers for liver cancer and osteosarcoma. Combined therapy with surgical resection after chemotherapy resulted in a significant decrease in serum tumor markers for liver cancer and osteosarcoma. AFP and L-3 are serum markers for the hepatic tumor, whereas LDH and ALP are serum markers for the osteosarcoma